CDC: Autism Prevalence Was 32.2 Per 1,000 8-Year-Olds in 2022

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on April 16, 2025.

By Elana Gotkine HealthDay Reporter

WEDNESDAY, April 16, 2025 -- The prevalence of autism spectrum disorder (ASD) was 32.2 per 1,000 children aged 8 years across 16 sites in the United States in 2022, according to research published in the April 17 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.

Kelly A. Shaw, Ph.D., from the CDC in Atlanta, and colleagues conducted an active surveillance program to estimate the prevalence and characteristics of ASD and monitor timing of ASD identification among children aged 4 and 8 years in 2022. Sixteen sites conducted surveillance in 2022.

The researchers found that the prevalence of ASD was 32.2 per 1,000 children across 16 sites among children aged 8 years in 2022, ranging from 9.7 to 53.1 in Texas (Laredo) and California, respectively. The prevalence of ASD was 3.4 times higher among boys than girls (49.2 versus 14.3). ASD prevalence was lower among non-Hispanic White children than among Asian or Pacific Islander, American Indian or Alaska Native, non-Hispanic Black or African American, Hispanic or Latino, and multiracial children (27.7 versus 38.2, 37.5, 36.6, 33.0, and 31.9, respectively). At 11 sites, there was no association observed between ASD prevalence and neighborhood median household income (MHI); at five sites, higher ASD prevalence was associated with lower MHI. At 13 sites able to abstract records, the cumulative incidence of ASD diagnosis or eligibility by age 48 months was higher for children born in 2018 than those born in 2014.

"Prevalence of ASD among children aged 8 years was higher in 2022 than previous years," the authors write. "Increased identification of autism, particularly among very young children and previously underidentified groups, underscores the increased demand and ongoing need for enhanced planning to provide equitable diagnostic, treatment, and support services for all children with ASD."

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-04-17 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords